TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

GRAVITI PHARMS

Infectious DiseaseCardiovascularGastroenterology
Generics

GRAVITI PHARMS is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology. Key products include ESOMEPRAZOLE MAGNESIUM.

2002
Since
15
Drugs
-
Trials
432
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-12
Manufacturing (CMC)
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
AMLODIPINE BESYLATE 2026-01-26
Manufacturing (CMC)
AMLODIPINE BESYLATE 2026-01-22
ATORVASTATIN CALCIUM 2026-01-22
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Gastroenterology 33%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease